Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - OnKure Therapeutics, Inc. | StockGist | StockGist

Companies
OKUR
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings OKURSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

OnKure Therapeutics, Inc.

Filed Feb 17, 2026

Accepted Feb 16, 2026, 7:00 PM ET

CIK 0001637715

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

793,602

Reporting Person

OnKure Therapeutics, Inc.

Person Type

IA

CUSIP: 68277Q105

Amendment History

4 filings

SCHEDULE 13G
Original
Viewing
Feb 17, 20260001104659-26-016660
SCHEDULE 13G/A
Amendment 1
Jan 30, 20260000102909-26-000240
SCHEDULE 13G/A
Amendment 2
Feb 17, 20260000902664-26-001088
SCHEDULE 13G/A
Amendment 3
Latest
Feb 17, 20260001104659-26-016541

Key Facts

Shares Owned

793,602

Recent Filings

OnKure Therapeutics, Inc.5 days ago

OnKure Therapeutics, Inc.3 weeks ago

OnKure Therapeutics, Inc.3 weeks ago

OnKure Therapeutics, Inc.1 months ago

OnKure Therapeutics, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice